FDA Adverse Event Malfunction Summary report: N

ALARIS® SYRINGE MODULE SET

MDR report key: 5628813 · Received May 3, 2016

Report

Report Number
9616066-2016-00640
Event Type
Malfunction
Date Received
May 3, 2016
Date of Event
March 26, 2016
Report Date
April 26, 2016
Manufacturer
CAREFUSION
Product Code
FPA
PMA / PMN Number
K811885
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NC, US
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

CONCOMITANT PRODUCTS: BAXTER 250ML IV BAG OF EXACTAMIX, REF H938737, LOT 1102114, EXP. 11/2018, THERAPY DATE (B)(6) 2016. THE AFFECTED PRODUCT HAS BEEN RECEIVED AND THE INVESTIGATION IS PENDING. A FOLLOW UP REPORT WILL BE SUBMITTED ONCE THE FAILURE INVESTIGATION HAS BEEN COMPLETED.

Additional Manufacturer Narrative · 1

ALTHOUGH REQUESTED, THE AFFECTED PRODUCT HAS NOT BEEN RECEIVED. A FOLLOW UP REPORT WILL BE SUBMITTED WITH INVESTIGATION RESULTS SHOULD THE AFFECTED PRODUCT BE RECEIVED FOR EVALUATION.

Additional Manufacturer Narrative · 1

THE CUSTOMER¿S REPORT OF A LEAK AT THE FILTER WAS CONFIRMED. INITIAL VISUAL INSPECTION SHOWED NO OBVIOUS DAMAGES OR ISSUES. FUNCTIONAL TESTING CONFIRMED LEAKING AT THE ENGAGEMENT BETWEEN THE DISTAL END OF THE FILTER AND THE TUBING. DIMENSIONAL ANALYSIS FOUND THE TUBING TO BE WITHIN SPECIFICATION. THE ROOT CAUSE OF THE LEAK AT THE FILTER WAS IDENTIFIED AS A MANUFACTURING ISSUE DUE TO INSUFFICIENT SOLVENT APPLIED AT THE ENGAGEMENT OF THE TUBING.

Description of Event or Problem · 1

THE CUSTOMER REPORTED AN INFUSION OF TPN WAS NOTED TO BE LEAKING AT THE FILTER AFTER INFUSING FOR LESS THAN 24 HOURS. THERE WAS NO PATIENT HARM.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
283560 ALARIS® SYRINGE MODULE SET SET, ADMINISTRATION, INTRAVASCULAR FPA CAREFUSION 10798696

Patients

Seq Age Sex Outcome Treatment
1 21 DA